Examine exhibits 57% discount in carcinogen publicity inside one week of sw – VAPES

228 0
Study shows 57% reduction in carcinogen exposure within one week of sw
– VAPES

Anti-vaping activists and big tobacco lobbyists often confuse the general public by making false claims that vaping is as deadly as smoking. Since scientists have been raising the alarm that smoking is highly carcinogenic for decades, the average citizen incorrectly assumes that vaping also causes cancer.

However, a recent study by researchers at the Roswell Park Institute in Buffalo, New York, shows that smokers who switch to vaping experience a significant decrease in carcinogenic exposure of at least 57 percent within the first 7 days and around 64 percent within the first have two weeks. The study entitled Exposure to Nicotine and Selected Toxins in Cigarette Smokers Who Switched to Electronic Cigarettes: A longitudinal observation study within the volunteers (NCBI) is carried out by the tobacco control specialist Dr. Maciej Goniewicz performed.

Overview of the Goniewicz study

The research team initially set out to determine the differences in nicotine exposure between smoking and vaping, but as their clinical study evolved, they came across some rather unexpected results. The researchers initially carefully selected a control group with twenty participants. Everyone had a long history of daily smoking and everyone agreed to switch completely to vaping. Double use was not permitted.

Related article: Big tobacco research shows that smoking increases significantly due to the "negative advertising" for vaping

Throughout the experiment, the scientists monitored each participant's steaming habits and simultaneously tracked several biomarkers. The aim was to compare the different exposure levels of nitrosamines, carcinogens, volatile organic compounds, polycyclic aromatic hydrocarbons, metals, metabolites and various toxins associated with combustible cigarettes by means of urine and blood sample analysis. To the researchers' astonishment, the average carcinogenic exposure had dropped a whopping 57 percent after just one week.

“Overall, 45% of the participants indicated complete abstinence from cigarette smoking after 2 weeks, while 55% said they continued to smoke. The total nicotine level and some polycyclic aromatic hydrocarbon metabolites did not change after switching from tobacco to e-cigarettes. All other biomarkers decreased significantly after 1 week of e-cigarette consumption (p <0.05). After 1 week, the largest percentage decrease in biomarker values ​​for 1,3-butadiene, benzene and acrylonitrile metabolites was observed. Total NNAL, a metabolite of NNK, decreased 57% and 64% after 1 and 2 weeks, respectively, while 3-hydroxyfluorene levels decreased by 46% in week 1 and by 34% in week 2. "

Of the twenty original participants, more than half were excluded from the process because they had not completely switched to vapes. However, around 45 percent have managed to give up smoking permanently, which in itself is a significant number. A success rate of this magnitude is much higher than the current statistics on more conventional nicotine replacement therapies (NRTs) for plasters, gums and lozenges.

In fact, the Roswell study appears to confirm the results of an earlier unrelated randomized clinical trial, the results of which were published in the New England Journal of Medicine in February 2019. In the later study, vaping was about twice as effective in quitting smoking compared to other NRTs manufactured and marketed by Big Pharma.

Related article: Vaping is twice as effective as NRTs for smoking cessation, new study says

(Courtesy of Shutterstock)

Leave a Reply